Harbour Trust & Investment Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$294K Hold
3,756
0.03% 130
2026
Q1
$325K Hold
3,756
0.03% 129
2025
Q4
$361K Sell
3,756
-50
-1% -$4.86K 0.04% 122
2025
Q3
$362K Sell
3,806
-654
-15% -$60.1K 0.04% 125
2025
Q2
$389K Buy
4,460
+536
+14% +$45.5K 0.04% 124
2025
Q1
$353K Sell
3,924
-146
-4% -$13.1K 0.04% 125
2024
Q4
$325K Sell
4,070
-278
-6% -$24.1K 0.04% 129
2024
Q3
$391K Sell
4,348
-191
-4% -$16.1K 0.04% 121
2024
Q2
$357K Buy
4,539
+576
+15% +$47.2K 0.04% 128
2024
Q1
$345K Buy
3,963
+196
+5% +$16.7K 0.04% 139
2023
Q4
$310K Buy
+3,767
New +$287K 0.04% 140

Other funds holding MDT

Harbour Trust & Investment Management's MDT Position: Q2 2026 in Review

Harbour Trust & Investment Management held its Medtronic (MDT) position steady in Q2 2026 at 3,756 shares worth $294K. The position accounts for 0.03% of the portfolio, ranked #130.

Harbour Trust & Investment Management first reported a position in MDT in Q4 2023 and has held it in 11 quarters since. The position peaked at $391K in Q3 2024. 959 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Harbour Trust & Investment Management held 3,756 shares of Medtronic worth $294K as of Q2 2026.
  • Harbour Trust & Investment Management left its Medtronic share count unchanged in Q2 2026.
  • Medtronic made up 0.03% of Harbour Trust & Investment Management's portfolio in Q2 2026, its #130 holding.
  • Harbour Trust & Investment Management first reported a position in Medtronic in Q4 2023 and has held it in 11 quarters since.
  • Harbour Trust & Investment Management's Medtronic position peaked at $391K in Q3 2024.
  • 959 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Harbour Trust & Investment Management's 13F filing for Q2 2026, filed 28 Jul 2026.